Two new drugs can slash stroke risk
Two new drugs could slash stroke risk and blood clots for those with atrial fibrillation, a heart rhythm problem, a study suggests.
The Food and Drug Administration said Wednesday that it would review of the safety of the widely used anemia drugs sold by Amgen and Johnson & Johnson after another clinical trial suggested that high doses of one of the drugs might cause strokes.